Printer Friendly

Study Identifies Promising New Drug Therapy for Feline Oral Cancer

About 10 percent of all tumors in cats are oral squamous cell carcinoma (OSCC), making this the third most common tumor in cats. Currently, surgery is the only effective treatment for feline OSCC, but for surgery to be curative, the disease must be identified early. Current chemotherapeutics have minimal efficacy in treatment of OSCC. To address this problem, researchers from the Ohio State University investigated a new class of anticancer drugs, histone deacetylase inhibitors, which have been found to inhibit tumor growth in humans and mice. They determined that histone deacetylase inhibitors do have anticancer effects on feline OSCC cells and have greater efficacy than traditional chemotherapy drugs, such as carboplatin and gemcitabine. Although the drug has proved to be effective for cats, more clinical trial testing is needed before it can be used in veterinary practice. Researchers hope these anticancer drugs may provide new therapies for cats suffering from OSCC. (D08FE-065)

Posted by MAFon June 22, 2011.

Categories: Cancer, Cat health, Feline health


Bookmark and Share

Post a Comment:

(max length 600 characters)
Enter this word: